Overview
The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an evidence-based practice guideline organization focused on improving the utilization of pharmacogenetics in clinical practice. It is composed of a network of experts in genetics, pharmacology, and clinical practice. CPIC is important because it provides evidence-based practice guidelines that help healthcare professionals ensure that medications are tailored to an individual patient’s genetic variations. This helps to optimize effectiveness and reduce the risk of adverse effects. CPIC guidelines are also important for researchers in pharmacogenetics and drug development, helping them to identify gene variants that may affect how a drug will work for a patient or how a patient will respond to a drug. Finally, CPIC also provides educational activities to help healthcare professionals, researchers, and the public understand and use pharmacogenetics, improving patient safety and care.